RT Journal Article SR Electronic T1 Occurrence of the Redifferentiation-Akin Phenomenon on 68Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation? JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP 290 OP 291 DO 10.2967/jnmt.120.241539 VO 48 IS 3 A1 Sharma, Priyanka A1 Basu, Sandip YR 2020 UL http://tech.snmjournals.org/content/48/3/290.abstract AB In this report, we present the 68Ga-DOTATATE PET/CT images of a patient with a metastatic neuroendocrine tumor with an intermediate-grade/Ki-67 index who had minimal somatostatin receptor positivity on baseline 68Ga-DOTATATE PET/CT but high-grade positivity on somatostatin receptor imaging (Krenning score, III–IV) on follow-up scans after chemotherapy. This redifferentiation-akin phenomenon in intermediate-grade neuroendocrine tumors after chemotherapy can have potential implications for the feasibility of peptide receptor radionuclide therapy in this group of patients in the later phase of their disease course.